<DOC>
	<DOC>NCT02699528</DOC>
	<brief_summary>To assess wether methylphenidate reduces the prevalence of primary nocturnal enuresis in children with attention deficit disorder</brief_summary>
	<brief_title>The Effect of Methylphenidate on Primary Enuresis in Children With Attention Deficit Hyperactivity Disorder</brief_title>
	<detailed_description>Children aged 5 - 10 years newly diagnosed with attention deficit hyperactivity disorder who report primary nocturnal enuresis, Investigators will obtain baseline data (from parents/caregivers) on their sleep habits and enuresis characteristics by questionnaire. After 6 weeks of methylphenidate therapy, prescribed for the attention deficit, a new questionnaire will be filled.</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Nocturnal Enuresis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>New diagnosis of attention deficit hyperactivity disorder History of primary nocturnal enuresis Normal neurological examination Anatomical abnormality of the genitourinary system Concommitant treatment, pharmacological/behavioral for enuresis Concommitant diurnal enuresis</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>